Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study
Keyword(s):
Abstract not available. Disclosures: Study sponsored by LEO Pharma. Copyright 2018 SKIN
2011 ◽
Vol 34
(8)
◽
pp. 853-861
◽
2021 ◽
Vol 85
(3)
◽
pp. AB144
Keyword(s):
2020 ◽
Vol 49
◽
pp. 102351
◽
Keyword(s):
2019 ◽
Vol 29
(2)
◽
pp. 357-367
◽
Keyword(s):
2005 ◽
Vol 95
(2)
◽
pp. 175-180
◽
2011 ◽
Vol 17
◽
pp. S24
◽
Keyword(s):